NTN BUZZTIME INC | License Agreements | Business Contracts

Exclusive License Agreement, dated February 20, 2023, by and between Factor Bioscience Limited and Eterna Therapeutics Inc (Filed With SEC on February 22, 2023)

First Amendment to Exclusive License Agreement, dated November 22, 2022, by and among Eterna Therapeutics Inc., Brooklyn Immunotherapeutics LLC, Novellus Therapeutics Limited and... (Filed With SEC on November 22, 2022)

Third Amended and Restated Exclusive License Agreement, dated November 1, 2020, by and between Factor Bioscience Limited and Novellus Therapeutics Limited (Filed With SEC on November 14, 2022)

Exclusive License Agreement, dated as of April 26, 2021, between Factor Bioscience Limited, Novellus Therapeutics Limited and Brooklyn ImmunoTherapeutics LLC (Filed With SEC on April 30, 2021)

NTN BUZZTIME INC (78) | License Agreements (4)